Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.
This major health threat is driving demand for more diagnostic tests and devices to treat cardiac problems.
Digital reality technologies are fast emerging as promising tools to aid physicians and patients. Western and Asian medtech companies are becoming big players in the growing market for these new applications in Asia.
The race to apply AI to medical treatment is rapidly accelerating in China and Japan.
Regional demand for more equipment and sophisticated treatment is expected to grow.
Before accepting money, the following is a guide to your due diligence process.
Many considerations should not be overlooked.
The country is trying to supplant the United States as the world leader in this sector.
It’s becoming more and more difficult for Western companies to make their way into this competitive market.
Access to the IVD market in China is lengthy and complicated.